Osteoarthritis (OA) is the most common joint disease, characterized by progressive destruction of the articular cartilage. The surface of joint cartilage is the first defensive and affected site of OA, but our knowledge of genesis and homeostasis of this superficial zone is scarce. EGFR signaling is important for tissue homeostasis. Immunostaining revealed that its activity is mostly dominant in the superficial layer of healthy cartilage but greatly diminished when OA initiates. To evaluate the role of EGFR signaling in the articular cartilage, we studied a cartilage-specific Egfr-deficient (CKO) mouse model (Col2-Cre EgfrWa5/flox). These mice developed early cartilage degeneration at 6 mo of age. By 2 mo of age, although their gross cartilage morphology appears normal, CKO mice had a drastically reduced number of superficial chondrocytes and decreased lubricant secretion at the surface. Using superficial chondrocyte and cartilage explant cultures, we demonstrated that EGFR signaling is critical for maintaining the number and properties of superficial chondrocytes, promoting chondrogenic proteoglycan 4 (Prg4) expression, and stimulating the lubrication function of the cartilage surface. In addition, EGFR deficiency greatly disorganized collagen fibrils in articular cartilage and strikingly reduced cartilage surface modulus. After surgical induction of OA at 3 mo of age, CKO mice quickly developed the most severe OA phenotype, including a complete loss of cartilage, extremely high surface modulus, subchondral bone plate thickening, and elevated joint pain. Taken together, our studies establish EGFR signaling as an important regulator of the superficial layer during articular cartilage development and OA initiation.
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EGFR | articular cartilage | chondrocyte | lubrication | osteoarthritis O steoarthritis (OA) is the most common chronic condition of the joints, affecting ∼27 million adults in the United States alone. Mature articular cartilage consists of four zones: superficial, transitional, middle, and calcified zones (1) . The combination of the first three zones are also termed uncalcified zone. Among them, the superficial layer is the first line of defense against OA initiation because of its surface location, unique composition, and functions. It has 2-4 layers of flat cells expressing unique molecules, such as proteoglycan 4 (Prg4, lubricin) and tenascin C, and contains a fine network of collagen fibrils that are oriented horizontally and parallel to the articular surface (2) . Its multifaceted roles include, but are not limited to, producing lubricant proteins, harboring chondroprogenitors, resisting shear stresses, serving as a gliding surface, and isolating deeper layers from synovial fluid (2) . In OA, degenerative changes initiate with cellular disorganization, gradual stiffening, and irregular surface of this layer (3) (4) (5) . Despite the critical role of superficial chondrocytes in maintaining articular cartilage and in blocking OA, its regulation by growth factors and hormones is still largely unknown.
Epidermal growth factor receptor (EGFR) signaling is important for tissue homeostasis. Multiple ligands bind to and activate the EGFR, including epidermal growth factor (EGF), transforming growth factor-α (TGFα), amphiregulin, heparin-binding EGF (HB-EGF), epiregulin, and betacellulin. Once activated, it stimulates an intracellular signal transduction cascade to markedly influence cell behavior (6). Our current knowledge of EGFR function in articular cartilage mostly came from previous studies of its ligands and its intracellular inhibitor, mitogen-inducible gene 6 (Mig-6). Large-scale gene profiling experiments have identified that the expression of TGFα (7) and HB-EGF (8) was increased in articular chondrocytes in both rodent surgical OA models and OA patients. Mig-6 null mice develop a severe OA-like joint degeneration phenotype at an early adult stage (9) . However, mice with limb-(Prx1-Cre) or cartilage-(Col2-Cre) specific deletion of Mig-6 showed a much milder OA phenotype (10) (11) (12) . Indeed, a
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This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. 1073/pnas.1608938113/-/DCSupplemental. common phenotype in these two conditional knockout models is an expansion of knee articular cartilage at a young age. In addition to EGFR, Mig-6 also suppresses the signaling of several other growth factor receptors, such as HGF/MET (13) , implicating that the cartilage phenotypes observed in Mig-6 null mice might not be solely due to EGFR overactivation.
In the past, we established a chondrocyte-specific Egfr knockout mouse model to demonstrate a pivotal role of EGFR signaling in growth plate development and secondary ossification center (SOC) formation (14, 15) . In this study, we used this model to investigate the function of EGFR in articular cartilage development. A surgery model by destabilization of the medial meniscus (DMM) was applied to elucidate the action of EGFR in OA initiation. Together with human cartilage data, our results clearly demonstrated that chondrogenic EGFR signaling is an essential regulator of the superficial layer of articular cartilage by maintaining chondrocyte number, its mechanical properties, and lubrication function. Furthermore, it plays a critical role in protecting cartilage from OA initiation.
Results EGFR Signaling in Healthy and Diseased Articular Cartilage. To study EGFR signaling in the articular cartilage, we first analyzed the gene expression of EGFR family members and its cognate ligands in mouse femoral head cartilage. Real-time RT-PCR revealed high levels of Egfr, its coreceptor Erbb2, and its ligands Tgfα, Hb-egf, amphiregulin, and epiregulin mRNA and relatively lower levels of other ligands, Egf and betacellulin (Fig. S1 ). Although all chondrocytes within articular cartilage were positive for EGFR staining (Figs. 1 A, b and 2 A, a), EGFR activity, indicated by phospho (p)-EGFR, was located mostly in surface chondrocytes and infrequently in calcified chondrocytes (Figs. 1 A, c and 2 A, b). DMM surgery induces OA-like phenotypes in mouse knees. At 1 mo after DMM, when articular cartilage had yet to show any morphological changes, EGFR staining remained throughout the cartilage, but p-EGFR staining had already been diminished at the surface ( Fig. 1 A, d-f ). In line with these data, healthy human articular cartilage exhibited strong EGFR staining throughout the cartilage (Fig. 1 B, b) and p-EGFR staining only at the superficial layer ( Fig. 1 B, c) . At an early OA stage, when the superficial zone (SZ) was still intact but proteoglycan staining was partially lost (Fig. 1 B, d ), p-EGFR staining was remarkably reduced (Fig. 1 B, f) . These expression and activity profiles strongly implicate a potential role of EGFR signaling in the SZ of healthy and diseased articular cartilage. ) mouse model ( Fig. S2 ) to investigate the action of EGFR in the articular cartilage. We previously demonstrated that EGFR activity in chondrocytes isolated from CKO mice and their sibling controls follows this sequence: WT > Wa5 >> CKO (15). Although CKO mice expressed EGFR ubiquitously in the articular cartilage ( Fig. 2 A, g ) due to the presence of a Wa5 allele, the amounts of p-EGFR and p-ERK, both EGFR signaling targets, were indeed drastically reduced compared with WT ( Fig. 2 A, h and i). Consistent with cell culture results, the staining patterns of p-EGFR and p-ERK in Wa5 cartilage were more similar to WT (Fig. 2 A, e and f).
At 2 mo of age, compared with WT and Wa5, Egfr CKO mice had slightly but noticeably reduced total thickness of articular cartilage ( Fig. 2 B and C and Fig. S3 ). At 6 mo of age, this reduction became much more evident in CKO mice, and Wa5 mice started to show similar changes. This drastic reduction of total thickness in CKO mice was accompanied by decreases in both uncalcified and calcified zones and an increase in the percentage of morphologically hypertrophied cells (Fig. 2C ). In addition, CKO cartilage had less Safranin O staining and exhibited histological defects, such as minor fibrillation and clefting at the cartilage surface, resulting in an early OA-like phenotype with a Mankin score of 6.8 ± 0.6 (Fig. 2D) .
EGFR Is Required for Maintaining Superficial Chondrocytes. Because cartilage surface possesses a high EGFR activity, we next took a close look at the SZ in CKO mice. Interestingly, although the structure of articular cartilage appeared normal in 2-wk-old animals ( Fig. 3 A, a-c and B) , the superficial layer in 2-mo-old Wa5 and CKO mice had 56.6% and 88.5%, respectively, less cells than that in WT mice (Fig. 3 A, d-f and B) . Decreases in chondrocyte cellularity were also noticeable in the rest of uncalcified cartilage but not as prominent as in the SZ (Fig. 3 A, f) . Those superficial cells in CKO mice had less Ki67 staining but more TUNEL staining, and their deeper layer showed positive type X collagen ( Fig. 3C and Fig. S4 ), suggesting that EGFR signaling is important for regulating the proliferative ability and cell survival of superficial chondrocytes and hypertrophy of chondrocytes. Consistently, activating EGFR by TGFα stimulated proliferation of cultured superficial chondrocytes (Fig. 3D) and increased resistance to apoptosis after serum depletion and TNFα treatment (Fig. 3E) . Upon chondrogenic differentiation, TGFα-treated cells maintained a flat cell shape and a low level of proteoglycan accumulation, whereas vehicle-treated cells became polygonal in shape and accumulated alcian blue-stained proteoglycan (Fig. 3 F and G) . Cotreatment of gefitinib, an EGFR inhibitor, abolished this effect of TGFα (Fig. 3G) . TGFα also attenuated the expression of two cartilage matrix genes, Col2 and aggrecan (Fig. 3H) . These data suggest a critical role of EGFR signaling in maintaining cell number and properties of superficial chondrocytes.
EGFR Signaling Promotes the Lubrication Function of Articular
Cartilage. One key function of superficial chondrocytes is producing boundary lubricants Prg4 and hyaluronic acid (HA). In WT joints, most cartilage and meniscus surfaces were covered by Prg4 (Fig. 4 A, a-c) and HA (Fig. 4 B, a-c) . Strikingly, Prg4 and HA signals were nearly absent at those surfaces in CKO joints (Fig. 4 A, e-g and B, e-g). Note that their amounts in synovial membrane were not affected (Fig. 4 A, d and h and B, d and h). These results are consistent with the p-EGFR staining pattern in our CKO model in which EGFR activity was also reduced at the meniscus surface but not in synovial membrane (Fig. S5) .
The loss of lubricants in CKO articular cartilage could be a direct regulatory effect of EGFR signaling on Prg4 expression or an indirect effect due to decreased superficial chondrocyte number. Indeed, primary culture experiments showed that TGFα stimulates Prg4 expression in chondrocytes in a time-dependent fashion ( Fig. S6A ) and that this up-regulation can be abolished by gefinitib (Fig. S6B) . Bovine articular cartilage explant represents a superior model to study the actions of growth factors under controlled and physiologically relevant conditions in a 3D environment. Using the uppermost 1 mm of bovine cartilage surface, we confirmed that TGFα increases Prg4 expression at both mRNA and protein levels in an EGFR-dependent manner (Fig. 4 C and D) , proving that EGFR autonomously regulates Pgr4 in the articular cartilage. Most importantly, tribological testing revealed that 3 d of TGFα treatment significantly reduces the equilibrium friction coefficient of articular surface by 28% (Fig. 4E) , demonstrating that EGFR signaling is an important regulator of cartilage lubrication function.
Deficiency of EGFR Signaling Weakens the Articular Cartilage. The principle function of articular cartilage is to provide load transmission and energy dissipative shock absorption during joint motion. Therefore, mechanical properties, mainly determined by cartilage extracellular matrix, are important parameters in characterizing cartilage function. Under the polarized light microscope, we observed that WT mice had mostly horizontally aligned collagen fibrils (in blue color, Fig. 5 A, b) at the cartilage surface and perpendicularly aligned fibrils (in red color, Fig. 5 A, b) with high collagen organization (high retardation values, Fig. 5 A, in the deep layers of cartilage. In contrast, the collagen fibrillar structure changed remarkably in the middle and calcified zones of CKO mice, resulting in random orientation of collagen fibers (mixed blue and red colors, Fig. 5 A, e) and reduced collagen organization (lower retardation values, Fig. 5 A, f) . Interestingly, these changes are very similar to the disruption of the collagen fibril network in OA. As shown in Fig. S7 , WT articular cartilage developed disoriented collagen fibrils and reduced collagen organization in the middle zone of degenerated cartilage at 2 mo after DMM.
We recently developed an atomic force microscopy (AFM)-based nanoindentation approach to accurately measure mouse cartilage surface mechanical properties. In line with the above polarized light microscopy data, we detected remarkable decreases in the effective nanoindentation modulus, E ind , in both Wa5 (58.7%) and CKO (74.7%) cartilage compared with WT (Fig. 5B) . These data also match our current observation that DMM surgery rapidly reduced surface E ind of WT mouse cartilage (16) . Taken together, our results clearly demonstrate that EGFR signaling regulates mechanical properties of articular cartilage.
Loss of EGFR in Chondrocytes Remarkably Accelerates Cartilage
Damage After DMM Surgery. Because the articular cartilage of Egfr CKO mice shows structural, functional, and mechanical defects, they should be prone to develop OA after joint instability. One month after DMM, while WT joints remained intact, CKO joints showed prominent cartilage damage, including surface fibrillation, clefts, and erosion ( Fig. 6 A, c) , as well as remarkable reductions in uncalcified and calcified cartilage thicknesses (Fig.  6B) . At 2 mo postsurgery, CKO joints developed a more severe phenotype with a large part of articular cartilage eroded at the medial site (Fig. 6 A, f) , resulting in a maximum Mankin score (Fig. 6C) . At 3 mo postsurgery, CKO joints lost almost the entire articular cartilage, with no measurements in both uncalcified and calcified cartilage thicknesses (Fig. 6 A, i and B) . Consistent with our previous report (17) , Wa5 DMM joints (Fig. 6 A, b , e, and h) had modestly accelerated OA development compared with WT, but their symptoms were much milder compared with CKO.
Consistent with these cartilage phenotypes, Egfr CKO mice developed several late OA phenotypes. First, although the lateral site of WT joints remained healthy, OA symptoms in CKO mice had propagated from the medial to lateral site ( Fig. 7 A and B) . Second, we observed a substantial increase in the thickness of the subchondral bone plate under the damaged cartilage area at the medial site in CKO mice (Fig. 7C) , suggesting a subchondral sclerosis phenotype. Third, E ind of the CKO DMM site increased remarkably to 4.3-fold of WT DMM joints, even more than WT sham joints (Fig. 7D) , suggesting that the indented surface on CKO DMM joints is most likely calcified cartilage or even subchondral bone. Note that at the same time, DMM resulted in a 67.2% reduction in E ind of articular cartilage surface in WT mice (Fig. 7D) . As OA further develops, the DMM site of WT mice also exhibited the same or elevated E ind compared with the sham site (16) . Fourth, pain is the major symptom in OA. To detect mechanical allodynia, we performed von Frey assay (18) and found that CKO DMM legs were extremely sensitive to the stimulus, with a paw withdrawal threshold (PWT) only 29.7% of that observed in WT DMM legs (Fig. 7E) , implicating that they experience much more pain than others after DMM. Lastly, although we did not observe any osteophyte in sham and DMM joints of 16 WT mice and 9 Wa5 mice, 6 out of 18 sham and 8 out of 18 DMM joints of Egfr CKO had osteophytes originating from either the tibial or femoral growth plate (Fig. 7F) . Combining all evidence together, we conclude that Egfr CKO mice reached the late stage of OA at 2 mo postsurgery through a pace much faster than WT mice. Additionally, we found that there are no changes in the trabecular bone structure in the metaphyseal area among WT, Wa5, and CKO mice regardless of surgery (Fig. S8 A and B) . Serum levels of bone formation (osteocalcin) and resorption (CTX) markers also remained the same among these mice (Fig. S8C) . These data clearly demonstrate that our CKO model has no effect on overall bone metabolism.
Discussion
The SZ is an indispensable part of articular cartilage and plays critical roles in maintaining the integrity and function of articular cartilage and preventing their degeneration. However, little is known about how growth factors and hormones, as well as their downstream signaling pathways, regulate superficial chondrocytes and their biological and mechanical functions. Our current studies identify EGFR and its ligands as an essential growth factor pathway that regulates chondrocyte number, boundary lubrication, and mechanical properties of this superficial layer. We found several EGFR ligands, such as Tgfα, Hb-egf, amphiregulin, and epiregulin, are expressed at abundant levels in mouse articular cartilage. Previous studies revealed that both TGFα (7) and HB-EGF (8) mRNA levels are increased in OA articular chondrocytes. Because activating EGFR by those ligands has both anabolic and catabolic activities on primary chondrocytes, whether an increase of EGFR ligand amount plays a destructive or a compensatively repairing role in OA is unclear. Nevertheless, our data demonstrate that reduction in EGFR activity leads to structurally, functionally, and mechanically compromised articular cartilage during development and drastically accelerates cartilage degeneration under normal and surgically induced OA conditions. Our data clearly showed that EGFR signaling is required for obtaining a sufficient number of superficial chondrocytes by preserving their proliferation ability, promoting their survival, and maintaining their superficial properties. Previous studies with chondrocyte-specific knockout of Mig-6 (10-12) also support our conclusion, as young mice exhibit hyperproliferation and hypercellularity in the top part of articular cartilage. A recent study identified Prg4-expressing cells located at the cartilage surface as chondrogenitors for deeper layers of the mature articular cartilage (19) . We also observed a decrease in chondrocyte cellularity in an uncalcified area below the superficial layer, accompanied with an increase in the percentage of hypertrophic chondrocytes. These data indicate that EGFR might regulate chondroprogenitors in the superficial layer of articular cartilage.
Prg4, an O-linked glycosylated protein, and HA, a polymer of disaccharides, coat the surface of articular cartilage, meniscus, and synovium and serve as two major boundary lubricants in the knee joints (20) . Our studies clearly identify EGFR signaling as an important pathway that promotes the production of Prg4 at the cartilage surface. Many studies suggest a synergistic interaction between Prg4 and HA to promote more effective boundary lubrication (21) (22) (23) . Interestingly, our data reveal that both lubricants are remarkably decreased in EGFR-deficient joints. How EGFR signaling regulates HA on the cartilage surface is not known. Because Prg4 is required to concentrate HA to the tissue surface (21) , an intriguing possibility is that EGFR indirectly regulates surface HA attachment by maintaining Prg4. Most importantly, our cartilage explant study explicitly demonstrated that EGFR signaling stimulates cartilage lubrication function. The reduced friction coefficient on the articular surface after TGFα treatment could result from the increased secretion of either PRG4 or both PRG4 and HA. In summary, future studies on the interactions among the superficial chondroprogenitor pool, lubricant secretion, and mechanical strength of cartilage surface using our Egfr CKO mouse model will likely provide more mechanistic insights into articular cartilage homeostasis.
Defective cartilage surface in CKO mice inevitably results in cartilage degeneration. At 2-3 mo after DMM, although WT and Wa5 mice only developed mild to moderate OA, CKO mice had already exhibited many late OA symptoms, such as a complete depletion of articular cartilage at the medial site, subchondral bone plate thickening underneath the damaged cartilage, moderate OA development at the lateral site, osteophyte formation, and a high level of joint pain. One potential concern of using our Egfr CKO mice to study OA progression, a disease in which subchondral bone also plays an important role, is that this model might not be chondrocyte-specific. A recent study implicated that Col2-Cre is capable of inducing fluorescence reporter expression in bone marrow mesenchymal progenitors (24) . Because our previous studies have demonstrated an important regulatory role of EGFR signaling on bone marrow mesenchymal progenitors (25) (26) (27) (28) , it is possible that OA symptoms observed in Egfr CKO mice might partially result from changes in bone remodeling. However, we found that trabecular bone in the secondary spongiosa and serum bone markers are not altered in CKO mice, suggesting that Col2 promoter-driven Cre does not efficiently delete the EGFR gene in bone marrow mesenchymal progenitors and thus does not affect bone formation directly. Our data indicate that Rosa-Tomato used in lineage tracing experiments seems to be a much more sensitive target for Cre than floxed Egfr allele in this Col2-Cre model.
Previous studies of EGFR signaling in articular cartilage development and degeneration focused on an indirect approach analyzing mice lacking Mig-6, an EGFR inhibitor (9) (10) (11) (12) . Because Mig-6 is not specific to EGFR, those results are too complicated to clearly interpret EGFR function. To our knowledge, this is the first study unambiguously demonstrating the important roles of EGFR signaling in maintaining articular cartilage homeostasis. Our results illustrate that EGFR mainly promotes anabolic activity in articular cartilage, which is opposite from its catabolic activity during growth plate development and SOC formation discovered in our previous reports (14, 15) . Because articular chondrocytes arise from a distinct progenitor population from growth plate and epiphyseal chondrocytes (29) , the EGFR function we identified in endochondral ossification may not be the same in articular cartilage. Furthermore, the severe OA progression observed in Egfr CKO mice after DMM clearly indicates a protective function of EGFR signaling on articular cartilage against OA degeneration, which is consistent with our previous observation that EGFR inhibitor (gefitinib) treatment via oral gavage in mice enhances cartilage destruction after DMM (17) . However, continuous infusion of another EGFR inhibitor, AG1478, in rats was shown to have opposite effects because it modestly delays OA progression after anterior cruciate ligament transection and partial medial meniscectomy (30) . Because Egfr CKO mice already have defects in the superficial layer of articular cartilage before injury, it is difficult to dissociate the level of importance of EGFR signaling in this region from its function in other regions during OA development. Interestingly, we observed a loss of EGFR activity in superficial chondrocytes in both human and mouse samples at the OA initiation stage. The underlying mechanism is not known, but it provides substantial evidence that EGFR signaling must play an important role in OA disease. Currently we believe that EGFR signaling has context-, stage-, and dose-dependent roles in OA progression. Future studies using inducible Egfr CKO mice with aggrecan-CreER (31) and superficial layer-specific knockout Prg4-CreER (19) are required to further elucidate spatiotemporal target cells and actions of this pathway and its effects on articular cartilage degeneration. Nevertheless, according to our studies, therapeutic agents specifically targeting cartilage surface EGFR should be considered as a novel direction for OA treatment.
Materials and Methods
All animal work performed in this report was approved by the Institutional Animal Care and Use Committee at the University of Pennsylvania. Details on animal studies, surgery, histology, human articular cartilage sample, AFMnanoindentation analysis, chondrocyte culture, bovine cartilage explant culture and friction test, real-time RT-PCR analysis, polarized light microscopy analysis, OA pain analysis, microcomputed tomorgraphy (microCT) analysis, and statistical analysis are presented in SI Materials and Methods and real-time PCR primer sequences are given in Table S1 .
